Centiva Capital’s Medifast MED Stock Holding History

Centiva Capital’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$471K	Buy	44,432 +22,410	+102%	+$258K	﹤0.01%	947
2026 Q1	$224K	Buy	22,022 +8,137	+59%	+$87.7K	﹤0.01%	1221
2025 Q4	$148K	Buy	+13,885	New	+$166K	﹤0.01%	1028
2024 Q4	–	Sell	-15,238	Closed	-$292K	–	2115
2024 Q3	$292K	Buy	15,238 +898	+6%	+$17.3K	0.01%	1596
2024 Q2	$313K	Buy	+14,340	New	+$382K	0.01%	1435
2024 Q1	–	Sell	-7,621	Closed	-$512K	–	2046
2023 Q4	$512K	Buy	7,621 +4,074	+115%	+$284K	0.01%	947
2023 Q3	$265K	Buy	+3,547	New	+$315K	0.01%	1240
2021 Q3	–	Sell	-747	Closed	-$211K	–	1486
2021 Q2	$211K	Buy	+747	New	+$202K	0.01%	1202

Other funds holding MED

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Centiva Capital's MED Position: Q2 2026 in Review

Centiva Capital increased its Medifast (MED) stake by 102% in Q2 2026, buying an estimated $258K and bringing the position to 44,432 shares worth $471K. The position accounts for ﹤0.01% of the portfolio, ranked #947.

Centiva Capital first reported a position in MED in Q2 2021 and has held it in 8 quarters since. The position peaked at $512K in Q4 2023. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

Centiva Capital held 44,432 shares of Medifast worth $471K as of Q2 2026.
Centiva Capital bought 22,410 Medifast shares in Q2 2026, an estimated $258K.
Medifast made up ﹤0.01% of Centiva Capital's portfolio in Q2 2026, its #947 holding.
Centiva Capital first reported a position in Medifast in Q2 2021 and has held it in 8 quarters since.
Centiva Capital's Medifast position peaked at $512K in Q4 2023.
113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.